278 related articles for article (PubMed ID: 3037926)
1. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
Charney DS; Woods SW; Goodman WK; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR; Breier A
Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
[TBL] [Abstract][Full Text] [Related]
4. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.
Charney DS; Woods SW; Heninger GR
Psychiatry Res; 1989 Feb; 27(2):173-82. PubMed ID: 2540501
[TBL] [Abstract][Full Text] [Related]
6. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014
[TBL] [Abstract][Full Text] [Related]
7. Increased anxiogenic effects of caffeine in panic disorders.
Charney DS; Heninger GR; Jatlow PI
Arch Gen Psychiatry; 1985 Mar; 42(3):233-43. PubMed ID: 2983630
[TBL] [Abstract][Full Text] [Related]
8. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
McDougle CJ; Krystal JH; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1995 Mar; 118(2):127-35. PubMed ID: 7617798
[TBL] [Abstract][Full Text] [Related]
9. Situational panic attacks. Behavioral, physiologic, and biochemical characterization.
Woods SW; Charney DS; McPherson CA; Gradman AH; Heninger GR
Arch Gen Psychiatry; 1987 Apr; 44(4):365-75. PubMed ID: 2882735
[TBL] [Abstract][Full Text] [Related]
10. Effects of yohimbine in obsessive compulsive disorder.
Rasmussen SA; Goodman WK; Woods SW; Heninger GR; Charney DS
Psychopharmacology (Berl); 1987; 93(3):308-13. PubMed ID: 2829264
[TBL] [Abstract][Full Text] [Related]
11. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.
Heninger GR; Charney DS; Price LH
Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008
[TBL] [Abstract][Full Text] [Related]
13. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.
Charney DS; Heninger GR; Sternberg DE
Life Sci; 1982 Jun; 30(23):2033-41. PubMed ID: 6287139
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC
Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422
[TBL] [Abstract][Full Text] [Related]
15. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.
Charney DS; Breier A; Jatlow PI; Heninger GR
Psychopharmacology (Berl); 1986; 88(2):133-40. PubMed ID: 3081923
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.
Krystal JH; McDougle CJ; Woods SW; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1992; 108(3):313-9. PubMed ID: 1355923
[TBL] [Abstract][Full Text] [Related]
17. Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects.
Woods SW; Charney DS; Goodman WK; Heninger GR
Arch Gen Psychiatry; 1988 Jan; 45(1):43-52. PubMed ID: 3122696
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine.
Price LH; Charney DS; Rubin AL; Heninger GR
Arch Gen Psychiatry; 1986 Sep; 43(9):849-58. PubMed ID: 3019271
[TBL] [Abstract][Full Text] [Related]
19. Possible mechanisms for lactate's induction of panic.
Liebowitz MR; Gorman JM; Fyer A; Dillon D; Levitt M; Klein DF
Am J Psychiatry; 1986 Apr; 143(4):495-502. PubMed ID: 3953891
[TBL] [Abstract][Full Text] [Related]
20. Lactate provocation of panic attacks. II. Biochemical and physiological findings.
Liebowitz MR; Gorman JM; Fyer AJ; Levitt M; Dillon D; Levy G; Appleby IL; Anderson S; Palij M; Davies SO
Arch Gen Psychiatry; 1985 Jul; 42(7):709-19. PubMed ID: 4015313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
